The Botanical and Plant Derived Drugs market is expected to grow from USD 35.21 billion in 2019 to USD 54.61 billion by 2026 at a CAGR of 6.1% from 2020 to 2026.
Botanical drugs are those medications which are derived from therapeutic plants. Plant determined medications are blend of plant and other affirmed sedates that contains plant materials, synthetic and semi manufactured substances. Botanical drugs comprise of vegetable material, green growth and plainly visible organisms. They are utilized in treatment of different diseases, for example cardiovascular sicknesses, different central nervous system disorders, irresistible infections and respiratory illnesses. Botanical drugs are available in various forms, for example, tablets, pills, injections and capsules.
The global Botanical and Plant Derived Drugs market is segregated on the basis of Product as Tablets, Capsules, Pills, and Injections. Based on Application the global Botanical and Plant Derived Drugs market is segmented in Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores.
The global Botanical and Plant Derived Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Botanical and Plant Derived Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers, Curaphar, and others are among the major players in the global Botanical and Plant Derived Drugs market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Botanical and Plant Derived Drugs market has been segmented as below:
Botanical and Plant Derived Drugs Market, By Product
Botanical and Plant Derived Drugs Market, By Application
Botanical and Plant Derived Drugs Market, By Region
Botanical and Plant Derived Drugs Market, By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global Botanical and Plant Derived Drugs market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Botanical and Plant Derived Drugs market share. Major industry players with significant revenue share include Abott Laboratories, Bayer Healthcare, Bionova, Bristol Myers, Curaphar, and others.
Why to Buy this Report:
Target Audience:
The report targeted towards the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
5.1 Introduction
5.2 Tablets
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Capsules
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Pills
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Injections
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6.1 Introduction
6.2 Hospital Pharmacies
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Retail Pharmacies
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Online Pharmacies
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Drug Stores
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7.1 Introduction
7.2 North America
7.2.1 North America Botanical and Plant Derived Drugs, By Product
7.2.2 North America Botanical and Plant Derived Drugs, By Application
7.3 Europe
7.3.1 Europe Botanical and Plant Derived Drugs, By Product
7.3.2 Europe Botanical and Plant Derived Drugs, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Botanical and Plant Derived Drugs, By Product
7.4.2 Asia-Pacific Botanical and Plant Derived Drugs, By Application
7.5 Rest of the World
7.5.1 Rest of the World Botanical and Plant Derived Drugs, By Product
7.5.2 Rest of the World Botanical and Plant Derived Drugs, By Application
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9.1 Abott Laboratories
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Bayer Healthcare
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Bionova
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Bristol Myers
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Curaphar
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
The global Botanical and Plant Derived Drugs market has been segmented as below:
Botanical and Plant Derived Drugs Market, By Product
Botanical and Plant Derived Drugs Market, By Application
Botanical and Plant Derived Drugs Market, By Region
Botanical and Plant Derived Drugs Market, By Company